104 related articles for article (PubMed ID: 26519548)
1. A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda.
Ngabo F; Levin A; Wang SA; Gatera M; Rugambwa C; Kayonga C; Donnen P; Lepage P; Hutubessy R
Vaccine; 2015 Dec; 33(51):7357-7363. PubMed ID: 26519548
[TBL] [Abstract][Full Text] [Related]
2. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.
Hutubessy R; Levin A; Wang S; Morgan W; Ally M; John T; Broutet N
BMC Med; 2012 Nov; 10():136. PubMed ID: 23146319
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia.
Simuyemba MC; Chama-Chiliba CM; Chompolola A; Sinyangwe A; Bchir A; Asiimwe G; Chibwesha C; Masiye F
BMC Infect Dis; 2024 Apr; 24(1):369. PubMed ID: 38565994
[TBL] [Abstract][Full Text] [Related]
4. Cost and operational context for national human papillomavirus (HPV) vaccine delivery in six low- and middle-income countries.
Mvundura M; Slavkovsky R; Debellut F; Naddumba T; Bayeh A; Ndiaye C; Anena J; Vodicka E; Diop A; Gamage D; Musanabaganwa C; Tatkan G; Driwale A; Zelalem M; Badiane O; Ginige S; Hamilton E; Sibomana H; Lakew Y; Uwinkindi F; Dhufera A; Ampeire I; Kumar S; Lamontagne DS
Vaccine; 2023 Nov; 41(49):7435-7443. PubMed ID: 37949752
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review.
Gibson E; Begum N; Sigmundsson B; Sackeyfio A; Hackett J; Rajaram S
Hum Vaccin Immunother; 2016 May; 12(5):1202-16. PubMed ID: 26837602
[TBL] [Abstract][Full Text] [Related]
6. Costs of delivering human papillomavirus vaccination using a one- or two-dose strategy in Tanzania.
Hsiao A; Struckmann V; Stephani V; Mmbando D; Changalucha J; Baisley K; Levin A; Morgan W; Hutubessy R; Watson-Jones D; Whitworth H; Quentin W
Vaccine; 2023 Jan; 41(2):372-379. PubMed ID: 36460537
[TBL] [Abstract][Full Text] [Related]
7. Costs of human papillomavirus vaccine delivery in low- and middle-income countries: A systematic review.
Slavkovsky R; Callen E; Pecenka C; Mvundura M
Vaccine; 2024 Feb; 42(6):1200-1210. PubMed ID: 38302338
[TBL] [Abstract][Full Text] [Related]
8. Global rotavirus vaccine introductions and coverage: 2006 - 2016.
Abou-Nader AJ; Sauer MA; Steele AD; Tate JE; Atherly D; Parashar UD; Santosham M; Nelson EAS
Hum Vaccin Immunother; 2018; 14(9):2281-2296. PubMed ID: 29787334
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination.
Ng SS; Hutubessy R; Chaiyakunapruk N
Vaccine; 2018 May; 36(19):2529-2544. PubMed ID: 29625764
[TBL] [Abstract][Full Text] [Related]
10. Assessing the incremental costs and savings of introducing electronic immunization registries and stock management systems: evidence from the better immunization data initiative in Tanzania and Zambia.
Mvundura M; Di Giorgio L; Vodicka E; Kindoli R; Zulu C
Pan Afr Med J; 2020; 35(Suppl 1):11. PubMed ID: 32373262
[TBL] [Abstract][Full Text] [Related]
11. Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond.
Chen S; Rodewald LE; Du AH; Tang S
Infect Dis Poverty; 2024 Mar; 13(1):25. PubMed ID: 38475849
[TBL] [Abstract][Full Text] [Related]
12. Funding gap for immunization across 94 low- and middle-income countries.
Ozawa S; Grewal S; Portnoy A; Sinha A; Arilotta R; Stack ML; Brenzel L
Vaccine; 2016 Dec; 34(50):6408-6416. PubMed ID: 28029541
[TBL] [Abstract][Full Text] [Related]
13. [Analysis on the implementation of payment policies for four non-national immunization program vaccines in China].
Zhong GJ; Wang MH; Ge JW; Yang J
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1843-1847. PubMed ID: 38008575
[TBL] [Abstract][Full Text] [Related]
14. Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.
Gandhi G; Lydon P
BMC Public Health; 2014 Jan; 14():67. PubMed ID: 24450832
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV) vaccination program in Sri Lanka: Ongoing costs and operational context of a routinized program.
Debellut F; Gamage D; Kumar S; Wickramasinghe S; Ruwanpathirana T; Kariyawasam M; Perera CS; Ginige S; Cooray N; Pecenka C; Slavkovsky R; Scott LaMontagne D; Mvundura M
Vaccine X; 2024 Mar; 17():100456. PubMed ID: 38379668
[TBL] [Abstract][Full Text] [Related]
16. An Evaluation of the Cost of Human Papilloma Virus (HPV) Vaccine Delivery In Zambia.
Simuyemba MC; Chama-Chiliba CM; Chompola A; Sinyangwe A; Bchir A; Asiimwe G; Masiye F; Chibwesha C
Res Sq; 2023 May; ():. PubMed ID: 37398262
[TBL] [Abstract][Full Text] [Related]
17. The cost of human papillomavirus vaccination delivery at the administrative and health facility levels in the Philippines.
Aldaba JG; Llave CL; Uy MEV; Tejano KP; Aquino MRC; Antonio P Catalig M; Sy ADR; Valverde HA; Mooney J; Slavkovsky R
Vaccine X; 2024 Mar; 17():100459. PubMed ID: 38420134
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of cost projections of new vaccine introduction.
Levin A; Yeung KHT; Hutubessy R
Vaccine; 2024 Feb; 42(5):1042-1050. PubMed ID: 38278630
[TBL] [Abstract][Full Text] [Related]
19. Understanding rapid implementation from discovery to scale: Rwanda's implementation of rotavirus vaccines and PMTCT in the quest to reduce under-5 mortality.
Sayinzoga F; Hirschhorn LR; Ntawukuriryayo JT; Beyer C; Donahoe KB; Binagwaho A
BMC Pediatr; 2024 Feb; 23(Suppl 1):649. PubMed ID: 38413897
[TBL] [Abstract][Full Text] [Related]
20. Childhood vaccines and antibiotic use in low- and middle-income countries.
Lewnard JA; Lo NC; Arinaminpathy N; Frost I; Laxminarayan R
Nature; 2020 May; 581(7806):94-99. PubMed ID: 32376956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
